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Abstract
Introduction Critically ill patients are characterized by increased
loss of muscle mass, partially attributed to sepsis and multiple
organ failure, as well as immobilization. Recent studies have
shown that electrical muscle stimulation (EMS) may be an
alternative to active exercise in chronic obstructive pulmonary
disease (COPD) and chronic heart failure (CHF) patients with
myopathy. The aim of our study was to investigate the EMS
effects on muscle mass preservation of critically ill patients with
the use of ultrasonography (US).
Methods Forty-nine critically ill patients (age: 59 ± 21 years)
with an APACHE II admission score ≥13 were randomly
assigned after stratification upon admission to receive daily
EMS sessions of both lower extremities (EMS-group) or to the
control group (control group). Muscle mass was evaluated with
US, by measuring the cross sectional diameter (CSD) of the
vastus intermedius and the rectus femoris of the quadriceps
muscle.
Results Twenty-six patients were finally evaluated. Right rectus
femoris and right vastus intermedius CSD decreased in both
groups (EMS group: from 1.42 ± 0.48 to 1.31 ± 0.45 cm, P =
0.001 control group: from 1.59 ± 0.53 to 1.37 ± 0.5 cm, P =
0.002; EMS group: from 0.91 ± 0.39 to 0.81 ± 0.38 cm, P =
0.001 control group: from 1.40 ± 0.64 to 1.11 ± 0.56 cm, P =
0.004, respectively). However, the CSD of the right rectus
femoris decreased significantly less in the EMS group (-0.11 ±
0.06 cm, -8 ± 3.9%) as compared to the control group (-0.21 ±
0.10 cm, -13.9 ± 6.4%; P < 0.05) and the CSD of the right
vastus intermedius decreased significantly less in the EMS
group (-0.10 ± 0.05 cm, -12.5 ± 7.4%) as compared to the
control group (-0.29 ± 0.28 cm, -21.5 ± 15.3%; P < 0.05).
Conclusions EMS is well tolerated and seems to preserve the
muscle mass of critically ill patients. The potential use of EMS as
a preventive and rehabilitation tool in ICU patients with
polyneuromyopathy needs to be further investigated.
Trial Registration clinicaltrials.gov: NCT00882830
Introduction
Critical illness polyneuromyopathy (CIPNM) is a common
complication of critical illness presenting with muscle weak-
ness, diminished tendon reflexes, difficult weaning from
mechanical ventilation [1,2], and prolonged intensive care unit
(ICU) and hospital stay [2,3], and is associated with increased
mortality [4]. CIPNM is reported to have an incidence ranging
from 25 to 50% [5,6] or higher [7] depending on the criteria
used for diagnosis and the patient population evaluated. In
afflicted patients muscle weakness may persist for months and
a percentage may never fully recover [8]. Intensive insulin ther-
apy has been proposed as a preventive therapy for CIPNM [9].
However, results from recent studies have raised concerns
regarding the safety and the mortality benefit of intensive insu-
lin therapy [10,11]. Despite its clinical significance, no preven-
tive or therapeutic tool has been proposed so far for CIPNM.
APACHE: Acute Physiology and Chronic Health Evaluation; CHF: chronic heart failure; CIPNM: critical illness polyneuromyopathy; COPD: chronic 
obstructive pulmonary disease; CSD: cross sectional diameter; EMS: electrical muscle stimulation; ICU: intensive care unit; SAPS: Simplified Acute 
Physiology Score; SOFA: Sequential Organ Failure Assessment; US: ultrasonography.Critical Care    Vol 13 No 5    Gerovasili et al.
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Muscle mass is a component of function and improvements in
the cross sectional area of a muscle have been shown to be
associated with the increased strength and force in health [12]
and disease [13]. Critically ill patients, especially those with
CIPNM, are characterized by increased loss of muscle mass
[14], partially attributed to sepsis and multiple organ failure,
the use of drugs such as neuromuscular blocking agents, as
well as immobilization. Sepsis is known to be a hypercatabolic
state for the muscle [15]. Immobilization, even of short dura-
tion, is also a catabolic state for the muscle resulting in signif-
icant loss of muscle mass in healthy subjects [16], as well as
in critically ill patients [17,18].
Electrical muscle stimulation (EMS) could be considered to be
an alternative to active exercise, which does not require patient
cooperation. EMS has been used in patients with severe
chronic obstructive pulmonary disease (COPD) [19,20] and
chronic heart failure (CHF) [21]. These patients cannot
actively exercise due to cardiac and respiratory insufficiency,
so they benefit from EMS in terms of exercise capacity [20-
22], skeletal muscle performance [19,20,22] and quality of life
[19,21]. EMS has been used in patients with severe COPD
under mechanical ventilation [19] but it has not been used so
far in critically ill ICU patients.
We hypothesized that EMS, as an alternative form of exercise,
will prevent the loss of muscle mass of critically ill patients. The
aim of our study was to assess the effect of EMS on muscle
mass preservation in critically ill patients with the use of ultra-
sonography (US).
Materials and methods
Patients
All patients admitted to our multidisciplinary ICU during the
study period were prospectively considered for inclusion in the
study. Exclusion criteria were: age under 18 years, pregnancy,
obesity (BMI >35 kg/m2), brain death, preexisting neuromus-
cular disease (e.g. myasthenia gravis), diseases with systemic
vascular involvement such as lupus erythematosus, technical
obstacles that did not allow the implementation of EMS such
as bone fractures or skin lesions (e.g. skin burns) and end-
stage malignancy. Patients with pacemakers and those with an
ICU stay of less than 48 hours were also excluded from the
study. The Sepsis Organ Failure Assessment (SOFA) [23],
Acute Physiology and Chronic Health Evaluation (APACHE) II
[24] and Simplified Acute Physiology Score (SAPS) 3 [25]
severity scores were calculated for all patients on the day of
admission. These scores have been developed for the assess-
ment of disease severity and have prognostic value in patients
admitted to the ICU. Patients with an APACHE II admission
score of 13 or higher underwent, on the second day after
admission, stratified randomization (age, gender) and were
assigned to the intervention group (EMS group) or to the con-
trol group. Patients assigned to the EMS group received daily
EMS sessions of both lower extremities (Table 1). Informed
consent was obtained from patients or from the patients' rela-
tives as approved by the Scientific Council and the Ethics
Committee of Evangelismos Hospital.
Electrical muscle stimulation session
EMS was implemented simultaneously on the quadriceps and
peroneous longus muscles of both lower extremities daily from
the second to ninth day after admission. In the case of hairy
skin, the skin was carefully shaven before the application. After
shaving and skin cleaning, rectangular electrodes (90 × 50
mm) were placed on the quadriceps and peroneus longus
muscles of both legs. The stimulator (Rehab 4 Pro, CEFAR
Medical AB, Malmö, Sweden) delivered biphasic, symmetric
impulses of 45 Hz, 400 μsec pulse duration, 12 seconds on
and 6 seconds off, at intensities able to cause visible contrac-
tions. In case of doubt, contraction was confirmed by palpation
of the muscles involved. Mean intensities used were 38 ± 10
mA (range 19 to 55 mA) for quads and 37 ± 11 mA (range 23
to 60 mA) for peroneous longus. The duration of the session
was 55 minutes including 5 minutes for warm up and 5 min-
utes for recovery. Sessions that took place were 81 ± 26%.
Assessment of muscle mass
Muscle mass was evaluated with US, by measuring the Cross
Sectional Diameter (CSD) of the quadriceps muscle (rectus
femoris - vastus intermedius) [26-28] on the day of randomiza-
tion (second day of admission) and seven or eight days after
the first assessment [29]. The choice of the ultrasonographic
measurement of quadriceps muscle was made, because it is
the largest muscle of the whole body, is easily accessible and
correlates well with lean tissue mass [30]. US images were
obtained using a GE Vivid 7 model ultrasound scanner with a
high frequency (7.5 MHz) linear transducer, appropriate for the
superficial structures [31]. This technique has been shown to
have very good intra- and inter-observer reproducibility [30].
The measurements were performed by two operators who
were blinded to the randomization, while the repetition of the
measurement was made by the same operator. All patients
were in the supine position with legs lying flat in extension. The
position of the probe was selected at the midway between the
anterior superior iliac spine and the midpoint of the patella and
was placed ventral to the transverse plane and perpendicular
to bone surface. To prevent impression of the skin, an excess
of gel was employed. To standardize the measurements, the
position of the probe was marked for the following measure-
ment.
Statistical analysis
All continuous variables are presented by mean ± standard
deviation. The within-patient changes were evaluated with Wil-
coxon. The differences between patients were evaluated by
nonparametric test (Mann-Whitney). The statistical signifi-
cance of P value was set at 0.05.Available online http://ccforum.com/content/13/5/R161
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Results
Two hundred and forty-seven patients were admitted to our
multidisciplinary ICU during the nine-month study period and
159 patients fulfilled the exclusion criteria or stayed in the ICU
less than 48 hours. The study population consisted of 88
patients of which 49 patients had an APACHE II admission
score of 13 or more. Of these patients, 24 were randomly
assigned to the EMS group and 25 to the control group. Ten
patients died or were discharged from the ICU before the sec-
ond measurement, 12 patients were excluded due to oedema
that interfered with the US measurements and 1 patient was
not measured due to technical reasons. In the EMS group, 5
patients were excluded due to oedema and 6 patients died or
were discharged before the second measurement. In the con-
trol group, 6 patients were excluded due to oedema, 5
patients died or were discharged before the second measure-
ment and 1 patient could not be measured due to technical
problems. Rectus femoris and vastus intermedius CSD could
be assessed in 26 patients, 13 in the EMS group and 13 in the
control group (Figure 1). In two patients the CSD of the left
rectus femoris and vastus intermedius could not be assessed
due to local oedema.
Baseline characteristics of patients randomly assigned to the
EMS group or the control group are shown in Table 1. All
patients were under mechanical ventilation (EMS group range
4 to 10 days, control group range 6 to 10 days) with the
exception of one patient assigned to the control group, who
was in need of respiratory support but was not mechanically
ventilated (Table 1).
Right rectus femoris (EMS group: from 1.42 ± 0.48 to 1.31 ±
0.45 cm, P = 0.001; control group: from 1.59 ± 0.53 to 1.37
± 0.5 cm, P = 0.002) and right vastus intermedius CSD (EMS
group: from 0.91 ± 0.39 to 0.81 ± 0.38 cm, P = 0.001; con-
trol group: from 1.40 ± 0.64 to 1.11 ± 0.56 cm, P = 0.004)
decreased significantly in both groups. However, the CSD of
the right rectus femoris decreased significantly less in the
EMS group (-0.11 ± 0.06 cm, -8 ± 3.9%) as compared with
the control group (-0.21 ± 0.10 cm, -13.9 ± 6.4%; P = 0.009
for the absolute difference and P = 0.029 for the relative dif-
ference) and the CSD of the right vastus intermedius
decreased significantly less in the EMS group (-0.10 ± 0.05
cm, -12.5 ± 7.4%) as compared with the control group (-0.29
Table 1
Baseline characteristics of critically ill patients randomly assigned to the EMS group or the control group (mean ± SD)
EMS group Control group P
Age (years) 59 ± 23 56 ± 19 NS
Gender (male/female) 6/7 8/5
APACHE II admission 19 ± 3 18 ± 6 NS
SOFA admission 10 ± 3 8 ± 3 NS
SAPS 3 admission 66 ± 9 61 ± 14 NS
Mechanical ventilation (days, n) 9 ± 2 (4-10), 13 9 ± 3 (6-10), 12
Reasons of ICU admission (n)
Sepsis 55
Trauma 43
Neurologic (including cerebrovascular) 24
Other 21
Sedation (days, n) 5 ± 4, 9 6 ± 4, 11
Vasopressors (days, n) 5 ± 4, 10 5 ± 4, 10
Hyperglycemia (days, n) 4 ± 3, 11 4 ± 3,10
Glucocorticoids (n) 4 4
Neuromuscular blockers (n) 2 2
Aminoglycosides (n) 6 7
Sepsis developed (n) 9 10
Hyperglycemia was defined as blood glucose level >140 mg/dl
Numbers in brackets signify range of values.
APACHE = Acute Physiology and Chronic Health Evaluation; EMS = electrical muscle stimulation; ICU = intensive care unit; NS = not significant; 
SAPS = Simplified Acute Physiology Score; SD = standard deviation; SOFA = Sequential Organ Failure Assessment.Critical Care    Vol 13 No 5    Gerovasili et al.
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± 0.28 cm, -21.5 ± 15.3%; P = 0.034 for the absolute differ-
ence and P = 0.05 for the relative difference; Figure 2).
Left rectus femoris (EMS group: from 1.34 ± 0.39 to 1.2 ±
0.41 cm, P = 0.001; control group: from 1.62 ± 0.55 to 1.43
± 0.6 cm, P = 0.014) and left vastus intermedius CSD (EMS
group: from 0.86 ± 0.36 to 0.77 ± 0.35 cm, P = 0.001; con-
trol group: from 1.53 ± 0.67 to 1.31 ± 0.65 cm, P = 0.050)
decreased significantly in both groups. However, the absolute
difference in the CSD of the left rectus femoris was signifi-
cantly less in the EMS group as compared with the control
group (-0.13 ± 0.10 cm vs. -0.19 ± 0.16, P = 0.07) and the
absolute difference in the CSD of the left vastus intermedius
was significantly less in the EMS group as compared with the
control group (-0.09 ± 0.05 cm vs -0.22 ± 0.26 cm, P =
0.018). The relative difference in the CSD of the left rectus
femoris and left vastus intermedius was less in the EMS group
as compared to the control group; however, the values did not
reach statistical significance (-11.7 ± 11.5% vs -13.5 ±
11.5%, P = 0.331 and -11.6 ± 7.5% vs -14 ± 21%, P =
0.167, respectively; Figure 3).
Discussion
The main finding of our randomized controlled study is that
EMS of lower extremities seems to preserve the muscle mass
of critically ill patients as assessed with US. To our knowledge,
this is the first study to show that EMS of lower extremities
applied to critically ill patients upon admission is associated
with a lesser degree of muscle mass loss of these patients as
assessed with US.
Figure 1
Schediagram of patients admitted to the ICU Schediagram of patients admitted to the ICU. APACHE = Acute Physiology and Chronic Health Evaluation; EMS = electrical muscle stimulation; 
ICU = intensive care unit.Available online http://ccforum.com/content/13/5/R161
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Critically ill patients undergo a state of hypermetabolism char-
acterized by an increase in energy expenditure [32]. This con-
dition is associated with increased protein loss, which to a
large extent is attributed to skeletal muscle protein loss
[18,32]. Moreover, immobilization even of short duration is
known to have detrimental effects on skeletal muscle in healthy
subjects [16] as well as in critically ill patients [14,18,19]. A
recent case report showed that the loss of skeletal muscle
mass may remain even after one year after ICU discharge
despite an extensive rehabilitation program [33]. In our study,
the muscle mass of critically ill patients as assessed with the
CSD by US decreased in both groups; however, the decrease
was significantly less in the intervention group. The CSD of the
rectus femoris muscle decreased by 13.9% within one week
in the control group. This severe loss of muscle mass during
the first week of ICU stay is in accordance with that reported
by other studies [14,17,32,33]. Therefore, a tool that could
reverse this process and preserve the muscle structure and
function, applied in the ICU setting would be desirable.
EMS has been used as an alternative to active exercise in
patients with severe COPD [19,20] and CHF [21,22]. In these
patients, EMS resulted in an improvement of muscle perform-
ance such as maximum voluntary contraction [20], muscle
strength and endurance [34,35] but also resulted in structural
changes of the muscle tissue [21]. In a recent study involving
bed-bound patients with COPD receiving mechanical ventila-
tion after ICU stay, EMS caused an increase in muscle
strength and reduced the number of days for transfer from bed
to chair [19]. Our study is the first to use EMS in critically ill
patients in order to evaluate directly its effect on muscle mass
preservation. However, in an early study, EMS was shown to
have beneficial effects on muscle metabolism in ICU patients
[36]. In our study, EMS during the first week of ICU stay pre-
served to a large extent the muscle mass of critically ill
patients. In a study involving patients with spinal cord injury,
three weeks of EMS increased the muscle thickness, as
assessed with US, to near normal values [37]. EMS was well
tolerated [38] and since it does not require the patient's coop-
Figure 2
(a) Absolute difference (cm) and (b) relative difference (%) in cross sectional diameter (CSD) of right rectus femoris and vastus intermedius in the  control (n = 13) and EMS (n = 13) groups (mean ± standard deviation) (a) Absolute difference (cm) and (b) relative difference (%) in cross sectional diameter (CSD) of right rectus femoris and vastus intermedius in the 
control (n = 13) and EMS (n = 13) groups (mean ± standard deviation). *significant between-group difference (P < 0.05). EMS = electrical muscle 
stimulation.
Figure 3
(a) Absolute difference (cm) and (b) relative difference (%) in cross sectional diameter (CSD) of left rectus femoris and vastus intermedius in the  control (n = 13) and EMS (n = 13) groups (mean ± standard deviation) (a) Absolute difference (cm) and (b) relative difference (%) in cross sectional diameter (CSD) of left rectus femoris and vastus intermedius in the 
control (n = 13) and EMS (n = 13) groups (mean ± standard deviation). *significant between-group difference (P < 0.05). EMS = electrical muscle 
stimulation.Critical Care    Vol 13 No 5    Gerovasili et al.
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eration it was easily applicable from the day of admission.
EMS, as an alternative form of exercise, may act as an anabolic
stimulus to the muscle reversing the catabolic effects of criti-
cal illness and immobilization.
The preservation of muscle mass was assessed with the use
of US by measuring the CSD of two muscles, namely the rec-
tus femoris and the vastus intermedius muscles. US is an eas-
ily applicable, non-invasive technique, which offers a cost-
effective alternative for the measurement of muscle thickness
[26,39]. Specifically, the thigh has been proposed for the
assessment of muscle wasting in critically ill patients because
it is well correlated with lean body mass [30].
Clinical implication
This study aimed to assess the role of EMS for the preserva-
tion of muscle mass. Although the role of physical, occupa-
tional and mobility therapy has been increased in recent years
[40,41], EMS is an alternative method of exercise causing min-
imal discomfort to patients who are not able to perform any
form of physical exercise, as is often the case in critically ill
patients. Functional evaluation and muscle strength would
have been the most appropriate endpoints in our study. How-
ever, functional and muscle strength evaluation requires
patient cooperation, which was not feasible for the majority of
critically ill patients on the seventh or eighth day after admis-
sion. It is a limitation of this study that it did not evaluate the
effect of EMS on the functional recovery or the muscle
strength of critically ill patients, which would have been clini-
cally significant endpoints. Further studies are needed to
explore the possible role of EMS as a tool for preserving the
muscle strength, the muscle properties and preventing
CIPNM in critically ill patients and to define which patients
would benefit most from this intervention.
Limitations
Anticipated limitations were the presence of oedema and the
extensive exclusion criteria that did not allow the evaluation of
the muscle mass in a considerable number of patients in both
legs of the study. Measurements can be confounded by
oedema. Oedema also distorts US images and does not allow
us to delimit rectus femoris and vastus intermedius. For these
reasons, patients with oedema were not measured. However,
the number of patients excluded due to oedema and early
death or discharge was equally distributed between the inter-
vention group and the control group.
Another limitation was the relatively small number of critically
ill patients that were evaluated, which is under power for defi-
nite conclusions. Finally, no data as to functional recovery of
the patients are reported in this study.
Conclusions
EMS is well tolerated and seems to preserve the muscle mass
of critically ill patients. Oedema has limited our conclusions
significantly and as a result our conclusions can only apply to
patients who do not develop oedema during their ICU stay.
Whether EMS can also preserve muscle structure and func-
tion and eventually prevent CIPNM in critically ill patients
needs to be further explored.
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